VEGFA and neoplasm: Our previous study showed that C16 treatment suppresses tumor progression by suppressing the proliferation of tumor cells and the expression of angiogenesis-related growth factors, such as vascular endothelial growth factor, platelet-derived growth factor, fibroblast growth factors, and epidermal growth factor in HCC19.